Rational design of multitarget-directed ligands: strategies and emerging paradigms

J Zhou, X Jiang, S He, H Jiang, F Feng… - Journal of medicinal …, 2019 - ACS Publications
Due to the complexity of multifactorial diseases, single-target drugs do not always exhibit
satisfactory efficacy. Recently, increasing evidence indicates that simultaneous modulation …

Virtual screening strategies in drug discovery: a critical review

A Lavecchia, C Di Giovanni - Current medicinal chemistry, 2013 - ingentaconnect.com
Virtual screening (VS) is a powerful technique for identifying hit molecules as starting points
for medicinal chemistry. The number of methods and softwares which use the ligand and …

Evolution of support vector machine and regression modeling in chemoinformatics and drug discovery

R Rodríguez-Pérez, J Bajorath - Journal of Computer-Aided Molecular …, 2022 - Springer
The support vector machine (SVM) algorithm is one of the most widely used machine
learning (ML) methods for predicting active compounds and molecular properties. In …

Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery

F Zhu, Z Shi, C Qin, L Tao, X Liu, F Xu… - Nucleic acids …, 2012 - academic.oup.com
Abstract Knowledge and investigation of therapeutic targets (responsible for drug efficacy)
and the targeted drugs facilitate target and drug discovery and validation. Therapeutic …

Getting the most out of PubChem for virtual screening

S Kim - Expert opinion on drug discovery, 2016 - Taylor & Francis
Introduction: With the emergence of the 'big data'era, the biomedical research community
has great interest in exploiting publicly available chemical information for drug discovery …

When good kinases go rogue: GSK3, p38 MAPK and CDKs as therapeutic targets for Alzheimer's and Huntington's disease

SR D'Mello - International Journal of Molecular Sciences, 2021 - mdpi.com
Alzheimer's disease (AD) is a mostly sporadic brain disorder characterized by cognitive
decline resulting from selective neurodegeneration in the hippocampus and cerebral cortex …

Advances with support vector machines for novel drug discovery

VG Maltarollo, T Kronenberger… - Expert opinion on …, 2019 - Taylor & Francis
Introduction: Novel drug discovery remains an enormous challenge, with various computer-
aided drug design (CADD) approaches having been widely employed for this purpose …

Prediction of chemical–protein interactions: multitarget-QSAR versus computational chemogenomic methods

F Cheng, Y Zhou, J Li, W Li, G Liu, Y Tang - Molecular BioSystems, 2012 - pubs.rsc.org
Elucidation of chemical–protein interactions (CPI) is the basis of target identification and
drug discovery. It is time-consuming and costly to determine CPI experimentally, and …

Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors

Y Li, C Tan, C Gao, C Zhang, X Luan, X Chen… - Bioorganic & medicinal …, 2011 - Elsevier
Multi-target EGFR, VEGFR-2 and PDGFR inhibitors are highly useful anticancer agents with
improved therapeutic efficacies. In this work, we used two virtual screening methods, support …

Dual-target kinase drug design: Current strategies and future directions in cancer therapy

D Sun, Y Zhao, S Zhang, L Zhang, B Liu… - European Journal of …, 2020 - Elsevier
Protein kinases are well-known to orchestrate the activation of signaling cascades in
response to extracellular and intracellular stimuli to control cell proliferation and survival …